Ministry of Health consultation on puberty blockers

The MHF does not support imposing additional and targeted restrictions on the prescribing of puberty blockers for transgender and gender-diverse young people in the absence of clear evidence for doing so. We are concerned that this would likely further exacerbate the already profound discrimination and mental health challenges faced by this group. We support preserving the current prescribing framework, while actively working toward improving access and care for these young people. We recommend the Ministry prioritise the views of trans youth, their whānau and support networks, and clinicians with the appropriate expertise as it shapes equitable health policy and research.